Table 1.
Study timepoints | Prescreen ing | Baseline | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Days 5–8 | Days 5–28 (as applicable) | Day 28 |
Prescreening | X | |||||||||
Informed consent | X | |||||||||
Eligibility criteria | X | |||||||||
Eligibility review if change in health information | X | |||||||||
Randomisation/treatment allocation | X | |||||||||
Baseline case report form | X | |||||||||
Nose swab collection (if child remains unwell) | X | X | X | X | X | |||||
Nose swab return | X | |||||||||
Intervention arm—HS drops | X | X | X | X | X | X | ||||
Daily diary | X | X | X | X | X | X | ||||
Adverse events | X | X | X | X | X | X | ||||
End of illness diary | ||||||||||
Satisfaction questionnaire | ||||||||||
Return of diaries | X | |||||||||
Day 28 wheeze question | X |
HS, hypertonic saline.